Aureon Labs names finance executive
-
- March
- 17
Aureon Laboratories Inc. named former ImClone Systems Inc. executive Ana I. Stancic as its chief financial officer, the biotechnology company said today.
Stancic joins the Yonkers-based company in the newly created post as its prepares bring its prostate cancer prognostic test to market later this spring.
Stancic most recently served as executive vice president and CFO at Omrix Biopharmaceuticals.
Prior to that, she was senior vice president of finance at ImClone, the Manhattan-based biopharmaceutical company that was at the center of Martha Stewart’s conviction of conspiracy and obstruction of justice charges in 2004.
This entry was posted
on Monday, March 17th, 2008 at 2:42 pm by David Schepp.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: 
| 
Print
| 
Email
